Scientists are excitedly investigating retatrutide, a innovative drug created by Eli Lilly, as a potential step in weight loss . Different than many previous approaches, retatrutide is a double -action compound targeting both GLP-1 and GIP, hormones that influence appetite and blood sugar contro